Treatment Information

Back

Ovarian Cancer treatment details. Chemotherapy.

University Hospital, Örebro, Örebro, Sweden.

Survival: monthsCountry:Sweden
Toxiciy Grade:3City/State/Province:Örebro
Treatments:ChemotherapyHospital:University Hospital, Örebro
Drugs:Journal:Link
Date:Jan 2013

Description:

Patients:
This study involved 108 epithelial ovarian cancer patients who had not received prior radiation therapy or chemotherapy. The average patient age was 63.3 years.
Treatment:
Patients were treated with the chemotherapy agents docetaxel and carboplatin

Toxicities:
The most severe toxicities were of grade 4 and included neutropenia and cardiac toxicity. Grade 3 infection was also reported.

Results:
The median overall survival was 35.3 months.

Support:
This study was supported by Sanofi-Aventis.

Correspondence: Dr. Bengt Sorbe; email: bengt.sorbe@orebroll.se



Back